赛升药业股东马丽、刘淑芹拟合计减持不超2%公司股份

Core Viewpoint - The shareholders of Sai Sheng Pharmaceutical plan to reduce their holdings by up to 9.63 million shares, representing no more than 2% of the company's total share capital [1] Shareholder Information - Shareholder Ma Li holds 29.84 million shares, accounting for 6.2% of the total share capital [1] - Shareholder Liu Shuqin holds 8.748 million shares, accounting for 1.82% of the total share capital [1] - Both Ma Li and Liu Shuqin are acting in concert with the company's controlling shareholder, Ma Qiang [1]